Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multigene assays in metastatic colorectal cancer.

Journal of the National Comprehensive Cancer Network : JNCCN - 1 Sept 2013

Deeb Kristin K, Sram Jakub P, Gao Hanlin, Fakih Marwan G

Abstract excerpt

Specific genomic colorectal cancer alterations are increasingly linked to prognosis and/or response to specific anticancer agents. The identification of KRAS mutations as markers of resistance to epidermal growth factor receptor (EGFR) inhibitors has paved the way to the interrogation of numerous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Colorectal Neoplasms
Share to ERCC1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to NRAS gene

Share to PTEN gene

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Neoplasm Metastasis

Source

Identifiers

PMID: 24158971
DOI: 10.6004/jnccn.2013.0221

Genes

EGFR
KRAS
BRAF
ERCC1
NRAS
PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24158971-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Multigene assays in metastatic colorectal cancer.PMID 24158971Read ↗

The Role of Multigene Panel Next-Generation Sequencing Techniques in Managing Patients with Metastatic Colorectal CarcinomaSemantic proximity Read ↗

Multigene Panel Next-Generation Sequencing Techniques in the Management of Patients with Metastatic Colorectal Carcinoma: The Way Forward for Personalized Treatment? A Single-Center Experience.Semantic proximity Read ↗

Current and Emerging Biomarkers in Metastatic Colorectal CancerSemantic proximity Read ↗

Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal CancerSemantic proximity Read ↗

Individualized therapy for metastatic colorectal cancer.Semantic proximity Read ↗

Optimal detection of clinically relevant mutations in colorectal carcinoma: sample pooling overcomes intra-tumoral heterogeneity.Semantic proximity Read ↗

Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations.Semantic proximity Read ↗

Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancerSemantic proximity Read ↗

EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer.Semantic proximity Read ↗

Intra-tumoral heterogeneity of KRAS and BRAF mutation status in patients with advanced colorectal cancer (aCRC) and cost-effectiveness of multiple sample testing.Semantic proximity Read ↗

Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.